Brief: Atea Pharmaceuticals Q2 Basic EPS USD -0.48
07/08/2024 21:05
Aug 07 (Reuters) - Atea Pharmaceuticals Q2 operating expenses USD 46.916 million. * Q2 operating income USD -46.916 million * Q2 pretax profit USD -40.279 million * Q2 net income USD -40.522 million
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM